By Sherri Oslick --
About
Court Report: Each week we will report briefly on recently filed
biotech and pharma cases, and a few interesting cases will be selected
for periodic monitoring.
Juridical Foundation The Chemo-Sero-Therapeutic Research Institute v. Doll
1:09-cv-01383; filed July 27, 2009 in the District Court of the District of Columbia
Review and correction of the patent term adjustment calculation made by the U.S. Patent and Trademark Office for U.S. Patent No. 7,482,436 ("Human Antihuman Interleukin-6 Antibody and Fragment of Antibody," issued January 27, 2009). View the complaint here.
Bayer Schering Pharma AG et al. v. Teva Pharmaceuticals USA Inc. et al.
1:09-cv-00536; filed July 24, 2009 in the District court of New Jersey
• Defendants: Teva Pharmaceuticals USA Inc.; Teva Pharmaceutical Industries Ltd.
Infringement of U.S. Patent No. 6,362,178 ("2-phenyl Substituted Imidazotriazinones as Phosphodiesterase Inhibitors," issued March 26, 2002) following a Paragraph IV certification as part of Teva's filing of an ANDA to manufacture a generic version of plaintiffs' Levitra® (vardenafil hydrochloride, used to treat erectile dysfunction). View the complaint here.
Comments